Austar Lifesciences (Austar Lifesciences) Long-Term Debt : $15.5 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Austar Lifesciences Long-Term Debt?

Austar Lifesciences's Long-Term Debt for the quarter that ended in Dec. 2023 was $15.5 Mil.

Austar Lifesciences's quarterly Long-Term Debt increased from Dec. 2022 ($5.7 Mil) to Jun. 2023 ($8.1 Mil) and increased from Jun. 2023 ($8.1 Mil) to Dec. 2023 ($15.5 Mil).

Austar Lifesciences's annual Long-Term Debt declined from Dec. 2021 ($8.5 Mil) to Dec. 2022 ($5.7 Mil) but then increased from Dec. 2022 ($5.7 Mil) to Dec. 2023 ($15.5 Mil).

Austar Lifesciences Long-Term Debt Historical Data

The historical data trend for Austar Lifesciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Austar Lifesciences Long-Term Debt Chart

Austar Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

8.52

5.75

15.52

Austar Lifesciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Debt	Get a 7-Day Free Trial															8.52	6.94	5.75	8.08	15.52

Austar Lifesciences (OTCPK:AULSF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Austar Lifesciences Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Austar Lifesciences's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Austar Lifesciences (Austar Lifesciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Austar Lifesciences Ltd (OTCPK:AULSF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

06118:Hong Kong

Address

No. 1018, Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN

Website

https://www.austar.com.hk

Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess Systems; Clean Room and Automation Control and Monitoring Systems; Powder and Solid Systems; Good Manufacturing Practice (GMP) Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.

Austar Lifesciences (Austar Lifesciences) Headlines

No Headlines